(NYSE:EBS), GAITHERSBURG, Md., Jan. 12, 2026 (GLOBE NEWSWIRE) — Today Emergent BioSolutions, Inc. (NYSE: EBS) announced it made a voluntary prepayment of $100 million under its outstanding term loan facility in late December 2025 using cash on hand. “This significant milestone reflects strong progress in improving our overall financial/cash position, enhancing our financial flexibility and […]

(NASDAQ:MDCX), PHILADELPHIA, Jan. 12, 2026 (GLOBE NEWSWIRE) — Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a precision guided biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics assets, is pleased to announce that detailed clinical data on Teverelix, its long-acting gonadotropin-releasing hormone (GnRH) antagonist, have been

(NasdaqGM:FCEL), DANBURY, Conn., Jan. 12, 2026 (GLOBE NEWSWIRE) — FuelCell Energy, Inc. (Nasdaq: FCEL) today announced the appointment of Amanda J. Schreiber as General Counsel and Corporate Secretary. Schreiber brings more than 20 years of legal, commercial, and governance leadership experience across global power generation, infrastructure, and multinational industrial organizations. She joins FuelCell Energy following

(NASDAQ:LXRX), SONATA-HCM on track for enrollment completion in 2026 and topline data in 2027 $10 million milestone payment triggered from licensing agreement with Novo Nordisk for LX9851 Zynquista on track for NDA resubmission and potential approval in 2026 Company presentation January 15 at 12:00 p.m. PT (3:00 p.m. ET) THE WOODLANDS, Texas, Jan. 12, 2026

(NASDAQ:SOPA),(NASDAQ:NUTR), JAKARTA, Indonesia, Jan. 12, 2026 (GLOBE NEWSWIRE) — Society Pass Incorporated (Nasdaq: SOPA) (the “Company“), Southeast Asia's (SEA) next generation e-commerce ecosystem, and its majority owned subsidiary, NusaTrip Incorporated (Nasdaq: NUTR) (“NusaTrip“), the leading SEA and Asia-Pacific-based (“APAC“) integrated travel technology platform, today announces that NusaTrip has formed a strategic partnership with Bookcabin, a

(NASDAQ:ADPT), SEATTLE, Jan. 12, 2026 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced preliminary, unaudited results for the fourth quarter and full year ended December 31, 2025. Total revenue

(NASDAQ:KELYA),(NASDAQ:KELYB), TROY, MI, Jan. 12, 2026 (GLOBE NEWSWIRE) — Kelly Services, Inc. (Nasdaq: KELYA, KELYB) (the “Company”), a leading specialty talent solutions provider, announced today that its Board of Directors (the “Board”) has unanimously adopted a stockholder rights plan (the “Rights Plan”). On Friday, January 9, 2026, the Terence E. Adderley Revocable Trust K (the

(NASDAQ:KUST), OVERLAND PARK, KS, Jan. 12, 2026 (GLOBE NEWSWIRE) — Kustom Entertainment, Inc. (Nasdaq: KUST) (the “Company”), today announced that it has closed the sale of its 51% ownership interest in Nobility Healthcare, LLC, its healthcare billing and revenue cycle management subsidiary. This step is in conjunction with its previously announced major corporate rebranding, by

(NasdaqGM:WVE), Wave expects to initiate a Phase 2a multidose portion of WVE-007 INLIGHT clinical trial in individuals living with obesity with higher BMI and comorbidities in 1H 2026, and initiate new trials of WVE-007 as an add-on to incretin and as post-incretin maintenance in 2026 Initial WVE-007 240 mg single-dose data reported in 2025 demonstrated

(NasdaqGM:XOMA),(NasdaqGM:XOMAO),(NasdaqGM:XOMAP), EMERYVILLE, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) — XOMA Royalty Corporation (“XOMA Royalty”) (Nasdaq: XOMA) announced today its Chief Financial Officer, Thomas Burns, will be stepping down from his position with XOMA Royalty to pursue other professional opportunities. “Tom's leadership, guidance, and resourcefulness have been invaluable as the Company transitioned to and established itself